Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up

Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%. However, the occurrence of a late thrombosis can compromise long-term results, particularly if the risks of this event were sustained. In this context, a registry of clinical cases gains special value. Objective: To evaluate the efficacy and safety of drug-eluting stents in the real world. Methods: We report on the clinical findings and 8-year follow-up parameters of all patients that underwent percutaneous coronary intervention with a drug-eluting stent from January 2002 to April 2007. Drug-eluting stents were used in accordance with the clinical and interventional cardiologist decision and availability of the stent. Results: A total of 611 patients were included, and clinical follow-up of up to 8 years was obtained for 96.2% of the patients. Total mortality was 8.7% and nonfatal infarctions occurred in 4.3% of the cases. Target vessel revascularization occurred in 12.4% of the cases, and target lesion revascularization occurred in 8% of the cases. The rate of stent thrombosis was 2.1%. There were no new episodes of stent thrombosis after the fifth year of follow-up. Comparative subanalysis showed no outcome differences between the different types of stents used, including Cypher®, Taxus®, and Endeavor®. Conclusion: These findings indicate that drug-eluting stents remain safe and effective at very long-term follow-up. Patients in the "real world" may benefit from drug-eluting stenting with excellent, long-term results.

Organisation, systematik und geographisches verhältniss der infusionsthierchen. Zwei vorträge, in der Akademie der wissenschaften zu Berlin gehalten in den jahren 1828 und 1830, von C.G. Ehrenberg. Mit 8 kupfertafeln in folio ...

Text

Synergistic inflammatory signaling in airway epithelial cells : control of expression levels of protease activated receptors and interleukin-8 release

Protease-activated receptor, interleukin, thrombin, trypsin, asthma

The Labdane Ent-3-Acetoxy-Labda-8(17), 13-Dien-15-Oic Decreases Blood Pressure In Hypertensive Rats

Abstract Background: Labdane-type diterpenes induce lower blood pressure via relaxation of vascular smooth muscle; however, there are no studies describing the effects of labdanes in hypertensive rats. Objective: The present study was designed to investigate the cardiovascular actions of the labdane-type diterpene ent-3-acetoxy-labda-8(17), 13-dien-15-oic acid (labda-15-oic acid) in two-kidney 1 clip (2K-1C) renal hypertension. Methods: Vascular reactivity experiments were performed in aortic rings isolated from 2K-1C and normotensive (2K) male Wistar rats. Nitrate/nitrite (NOx) measurement was performed in aortas by colorimetric assay. Blood pressure measurements were performed in conscious rats. Results: Labda-15-oic acid (0.1-300 µmol/l) and forskolin (0.1 nmol/l - 1 µmol/l) relaxed endothelium-intact and endothelium-denuded aortas from both 2K-1C and 2K rats. Labda-15-oic acid was more effective at inducing relaxation in endothelium-intact aortas from 2K pre-contracted with phenylephrine when compared to the endothelium-denuded ones. Forskolin was more potent than labda-15-oic acid at inducing vascular relaxation in arteries from both 2K and 2K-1C rats. Labda-15-oic acid-induced increase in NOx levels was lower in arteries from 2K-1C rats when compared to 2K rats. Intravenous administration of labda-15-oic acid (0.3-3 mg/kg) or forskolin (0.1-1 mg/kg) induced hypotension in conscious 2K-1C and 2K rats. Conclusion: The present findings show that labda-15-oic acid induces vascular relaxation and hypotension in hypertensive rats.

Total synthesis of 8,9-Dehydro-Epothilone C

Magdeburg, Univ., Fak. für Verfahrens- und Systemtechnik, Diss., 2010

Motor- und Aggregate-Akustik : 8. Magdeburger Akustik-Symposium ; Tagungsband [02. und 03. Juli 2014]

Hermann Rottengruber; Wilfried Henze; Tommy Luft (Hrsg.) und 54 Mitautoren

Qualifizierung einer Destillationsapparatur für die Herstellung von gereinigtem Wasser nach PhEur 8

In der Arbeit wird die Qualifizierung eines Wasserdestillationsapperates durchgeführt. Die Qualifizierung beinhaltet die Designqualifizierung (DQ), Installationsqualifizierung (IQ), die Funktionsqualifizierung (OQ) und die Leistungsqualifizierung (PQ). Die Qualifizierung wird nach GMP durchgeführt. GMP ist die Richtlinie für die Qualifizierung von Geräten und die Herstellung von Arzneimitteln. Bei der Leistungsqualifizierung wird das hergestellte Wasser nach dem europäischen Arzneibuch überprüft. Es werden drei Prüfungen durchgeführt, um die Menge an Mikroorganismen, die Leitfähigkeit und den TOC-Wert zu bestimmen. Die erhaltenen Ergebnisse und Messwerte werden in Qualifizierungsprotokollen zusammengefasst, aus denen hervorgeht, ob der geprüfte Wasserdestillierapperat den Anforderungen entspricht.

Programação do gladíolo (Gladiolus grandiflorus) andr. cv. Snow Princess, através de cormilhos tipo 7 e 8

Os cormilhos tipo 7 produziram bulbos e cormilhos dos tipos de 1 a 8 em maior quantidade que o tipo 8 e os bulbos tipos 1, 2, 3, 4 e 5 mais pesados. Os cormilhos tipo 8 também produziram bulbos e cormilhos dos tipos 1 a 8, porém seus cormilhos foram mais pesados que os cormilhos produzidos pelo tipo 7.

The Indian tribes of the Chicago region, with special reference to the Illinois and the Potawatomi / by William Duncan Strong -- Former Assistant Curator of North American Ethnology and Archaeology. 8 plates.

no.24(1926)